Trial intelligence / Profile preview

Sunitinib and Paclitaxel in Advanced Esophageal Cancer

NCT00730353Phase 2Completed

Sponsor
Hoosier Cancer Research Network
Start
Aug 2008
Primary completion
Mar 2010
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of sunitinib in esophageal cancer, sponsored by Hoosier Cancer Research Network. Started Aug 2008; status: completed.

02

Drugs

sunitinib
03

Conditions

esophageal cancer

Beyond the preview

Go deeper on NCT00730353.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00730353.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call